supplementhackr
Pharmaxa Labs

Phenocal

Serving
3 Capsule(s)
Per container
30
Form
capsule-unknown
UPC
659459814531
DSLD
306936
Formula hash
a05f840de42e
Brand context
Pharmaxa Labs
Catalog
32
products
With avoid flag
7
products
FDA recalls
0
history
CAERS
0
reports
Avoid-flaggedObjective label signals
Flagged excipients
3
1 avoid · 2 caution
FDA recalls
0
no recall history
CAERS reports
0
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

13 active ingredients
IngredientAmount% DV
Vitamin D
vitaminUNII · 9VU1KI44GP
UL · set4 effects
25 mcg125%
Thiamine
ThiaminvitaminUNII · X66NSO3N35
3 effects
10 mg833%
Riboflavin
vitaminUNII · TLM2976OFR
5 effects
5 mg385%
Niacin
vitaminUNII · 2679MF687A
UL · set3 effects
25 mg156%
Vitamin B6
vitaminUNII · KV2JZ1BI6Z
UL · set6 effects
6 mg353%
Folate
vitaminUNII · 935E97BOY8
UL · set2 effects
83.3 mcg DFE21%
Vitamin B12
vitaminUNII · 8406EY2OQA
3 effects
50 mcg2083%
Biotin
vitaminUNII · 6SO6U10H04
3 effects
50 mcg167%
Pantothenic Acid
Pantothenic Acid (Vitamin B5)vitaminUNII · 19F5HK2737
10 mg200%
Chromium
mineralUNII · 0R0008Q3JB
1 effect
100 mcg286%
Proprietary Blend
Proprietary Blend (Combination)other
2.23 Gram(s)—
Fucoxanthin
herbUNII · 06O0TC0VSM
10 mg—
Bioperine
Black PepperherbUNII · KM66971LVF
2.5 mg—
What this product supports · authorized claims

14 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

3 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

    eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C Yellow #5
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

    eur-lex.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C Yellow #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

    eur-lex.europa.eu →
Other ingredients

Gelatin · Magnesium Stearate